期刊
CANCER LETTERS
卷 354, 期 1, 页码 21-27出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2014.08.013
关键词
Mesenchymal uterine tumors; Endometrial stromal sarcomas; Chemotherapy; Histone deacetylase inhibitors; Vorinostat
类别
资金
- Lore Saldow Research Fund
Endometrial stromal sarcoma (ESS) and undifferentiated endometrial sarcoma (UES) are very rare gynecologic malignancies. Due to the rarity and heterogeneity of these tumors, little is known about their epidemiology, pathogenesis, and molecular pathology. Our previous studies have described deregulation of histone deacetylases expression in ESS/UES samples. Some of these enzymes can be inhibited by substances which are already approved for treatment of cutaneous T-cell lymphoma. On the basis of published data, they may also provide a therapeutic option for ESS/UES patients. Our review focuses on molecular mechanisms of ESS/UES. It describes various aspects with special emphasis on alteration of histone deacetylation and its possible relevance for novel therapies. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据